And so we all return from the weekend. Hope yours was enjoyable. Ours was splendid. We managed to mow the lawn yesterday, a rare event that met with the approval of the neighbors (not that we care all that much). And we took the shortest of the short people on a hayride to pick a few pumpkins. Now, though, we are again scouring the world for interesting insights. Here are a few of the latest...
EU Delays Schering-Plough, Organon Review For Two Weeks (CNNMoney/Dow Jones)
EU Approves Pfizer's Selzentry AIDS Drug (Yahoo/Reuters)
Glaxo Wins EU Approval To Sell Cervarix HPV Vaccine (Bloomberg News)
Novartis' Exelon Alzheimer's Patch Approved By EU (CNN/Thomson Financial)
Lilly Sues Sun Pharma To Block Generic Version Of Strattera (Bloomberg News)
FDA Delays Approval Of Glaxo Seizure Drug (Yahoo/Reuters)
At FDA, Janet Woodcock To Replace Steve Galson As Acting CDER Director (press release)
Rochester, NY, To Monitor Gardasil Effect (Rochester Democrat & Chronicle)
Alantos Pharma To Cut 45 Jobs In Massachusetts And Germany (The Boston Globe)
Celgene To Pay $540M To Array BioPharma For Compounds (Bloomberg News)
1 Comment
"Janet Woodcock to replace Steve Galson"
Hell, that sure is a nightmare in the making!